Evidence map›Paper›PMID 31783432›Full record

ArticleHepatology research : the official journal of the Japan Society of Hepatology2020

Zinc deficiency in patients with chronic liver disease in Japan.

Itaru Ozeki, Tomohiro Arakawa, Hirokazu Suii, Ryoji Tatsumi, Masakatsu Yamaguchi, Tomoaki Nakajima, Yasuaki Kuwata, Joji Toyota

Open access · hybridAbstract read
In one paragraph

Article in Hepatology research : the official journal of the Japan Society of Hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Observational
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Zinc deficiency in patients with chronic liver disease in Japan.Hepatology research : the official journal of the Japan Society of Hepatology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Itaru OzekiDepartment of Hepatology, Sapporo Kosei General Hospital, Sapporo, Japan.
Tomohiro ArakawaDepartment of Hepatology, Sapporo Kosei General Hospital, Sapporo, Japan.
Hirokazu SuiiDepartment of Hepatology, Sapporo Kosei General Hospital, Sapporo, Japan.
Ryoji TatsumiDepartment of Hepatology, Sapporo Kosei General Hospital, Sapporo, Japan.
Masakatsu YamaguchiDepartment of Hepatology, Sapporo Kosei General Hospital, Sapporo, Japan.
Tomoaki NakajimaDepartment of Hepatology, Sapporo Kosei General Hospital, Sapporo, Japan.
Yasuaki KuwataDepartment of Hepatology, Sapporo Kosei General Hospital, Sapporo, Japan.
Joji ToyotaDepartment of Hepatology, Sapporo Kosei General Hospital, Sapporo, Japan.
Sapporo Kosei General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis study aimed to determine the distributions of serum zinc levels and the prevalence of zinc deficiency in patients with chronic liver disease (CLD) in actual clinical practice, and to analyze the association between serum zinc levels and clinical characteristics.

methodsThis study analyzed 1973 patients with CLD, including 749 with liver cirrhosis, who were admitted to Sapporo Kosei General Hospital in 2017.

resultsZinc deficiency, defined as a serum zinc level of <60 μg/dL, was observed in 555 patients overall (28.1%), including 182 (14.9%) patients without liver cirrhosis and 373 (49.8%) with liver cirrhosis. When marginal zinc deficiency was included, zinc deficiency (serum zinc level <80 μg/dL) was observed in 1594 (80.8%) patients overall, including 924 (75.5%) patients without liver cirrhosis and 670 (89.5%) with liver cirrhosis. Serum zinc levels were most strongly correlated with serum albumin levels. Of the 257 CLD patients with an albumin level of <3.5 g/dL, 234 (91.1%) had a serum zinc level of <60 μg/dL.

conclusionsZinc deficiency is common in patients with CLD. Serum zinc levels should be regularly measured, particularly in patients with liver cirrhosis.

Indexed as

chronic liver diseasesliver cirrhosiszinc

Identifiers

PMID31783432
PMCPMC7079247
OpenAlexW2989921932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.